A Phase I Study to Evaluate the Safety and Tolerability of SX-682 in Combination with anti-pd1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma
ANNALS OF SURGICAL ONCOLOGY(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ANNALS OF SURGICAL ONCOLOGY(2022)